In a time of increasingly personalized healthcare, Elizabeth Philp has become a formidable force of innovation, especially in the tech-driven field of compounded pharmacy. As the co-founder and CEO of Roseway Labs, Philp is at the vanguard of a movement to make bespoke medications more available, challenging the standard one-size-fits-all approach